| For: | Parvaiz F, Manzoor S, Iqbal J, Sarkar-Dutta M, Imran M, Waris G. Hepatitis C virus NS5A promotes insulin resistance through IRS-1 serine phosphorylation and increased gluconeogenesis. World J Gastroenterol 2015; 21(43): 12361-12369 [PMID: 26604643 DOI: 10.3748/wjg.v21.i43.12361] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i43/12361.htm |
| Number | Citing Articles |
| 1 |
Sundararaj Stanleyraj Jeremiah, Abu Saleh Md Moin, Alexandra E. Butler. Virus-induced diabetes mellitus: revisiting infection etiology in light of SARS-CoV-2. Metabolism 2024; 156 doi: 10.1016/j.metabol.2024.155917
|
| 2 |
Héctor Jesús Maldonado-Garza, Jesús Zacarías Villarreal-Pérez, Emmanuel Irineo González-Moreno, Fernando Javier Lavalle-González, José Alberto González-González, Diego García-Compeán. Hepatogenous diabetes: Is it a neglected condition in chronic liver disease?. World Journal of Gastroenterology 2016; 22(10): 2869-2874 doi: 10.3748/wjg.v22.i10.2869
|
| 3 |
Esther Rey, Javier Ampuero, Francisca Molina‐Jiménez, Patricia Marañón, Yaiza García‐García, Rocío Múñoz‐Hernández, Manuel Romero‐Gómez, Carmelo García‐Monzón, Pedro Majano, Águeda González‐Rodríguez. Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation. Clinical and Translational Medicine 2021; 11(1) doi: 10.1002/ctm2.275
|
| 4 |
Fanxing Xu, Jing Yang, Hiroko Negishi, Yue Sun, Dahong Li, Xianxian Zhang, Toshihiko Hayashi, Ming Gao, Katsumi Ikeda, Takashi Ikejima. Silibinin decreases hepatic glucose production through the activation of gut–brain–liver axis in diabetic rats. Food & Function 2018; 9(9) doi: 10.1039/C8FO00565F
|
| 5 |
Cristina Vassalle, Antonella Meloni, Laura Pistoia, Alessia Pepe. LIVER PANCREAS HEART TRIANGLE AND HCV IN THALASSEMIA: EXPANDING THE HORIZON THROUGH BIOMARKER NETWORKS. International Journal of Hematology and Therapy 2017; 3(1) doi: 10.15436/2381-1404.17.017
|
| 6 |
Nalan Okuroglu, Meltem Sertbas, Ali Ozdemir. Treatment of Chronic Hepatitis C Can Improve Glycemic Control in Patients with Type 2 Diabetes. Case Reports in Hepatology 2018; 2018 doi: 10.1155/2018/5260510
|
| 7 |
Libao Wang, Qiuwen Xu, Zhijun Yu, Zhenxin Hu, Hui Li, Wenjun Shi, Xihe Wan. Transcriptomic Analysis Provides Insights into the Energetic Metabolism and Immune Responses in Litopenaeus vannamei Challenged by Photobacterium damselae subsp. damselae. Fishes 2024; 9(9) doi: 10.3390/fishes9090350
|
| 8 |
Laure Perrin-Cocon, Cindy Kundlacz, Clémence Jacquemin, Xavier Hanoulle, Anne Aublin-Gex, Marianne Figl, Jeremy Manteca, Patrice André, Pierre-Olivier Vidalain, Vincent Lotteau, Olivier Diaz. Domain 2 of Hepatitis C Virus Protein NS5A Activates Glucokinase and Induces Lipogenesis in Hepatocytes. International Journal of Molecular Sciences 2022; 23(2) doi: 10.3390/ijms23020919
|
| 9 |
Patricia Olguín-León, Tania Enríquez-Espinoza, Fernando Mendoza-Cano, Trinidad Encinas-García, Arturo Sánchez-Paz. Transcriptional profile of pyruvate kinase and pancreatic lipase encoding mRNAs of the Pacific whiteleg shrimpPenaeus vannameiduring PstDV-1 infection. Aquaculture Research 2017; 48(11) doi: 10.1111/are.13380
|
| 10 |
Amirhossein Shahpar, Vahideh Hamidi Sofiani, Nazanin Zeinali Nezhad, Marzieh Charostad, Reza Ghaderi, Niloofar Farsiu, Amin Karimzadeh Kiskani, Sara Pezeshki, Mohsen Nakhaie. A narrative review: exploring viral-induced malignancies through the lens of dysregulated cellular metabolism and glucose transporters. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-13013-y
|
| 11 |
Mohamed Mohei El Badry, Doaa Abdelhady Ali, Noha Hamdy Eltaweel, Marwa A. Abdel-Wahed. Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control. Egyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00061-9
|
| 12 |
Olivier Diaz, Pierre-Olivier Vidalain, Christophe Ramière, Vincent Lotteau, Laure Perrin-Cocon. What role for cellular metabolism in the control of hepatitis viruses?. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1033314
|
| 13 |
Yaping Xin, Dongming Zhang, Yanqin Fu, Chongxian Wang, Qingju Li, Chenguang Tian, Suhe Zhang, Xiaodong Lyu. C1qTNF-related protein 1 improve insulin resistance by reducing phosphorylation of serine 1101 in insulin receptor substrate 1. Endocrine Journal 2017; 64(8) doi: 10.1507/endocrj.EJ17-0128
|
| 14 |
Carla Carnovale, Marco Pozzi, Alice Dassano, Francesca D’Addio, Marta Gentili, Carlo Magni, Emilio Clementi, Sonia Radice, Paolo Fiorina. The impact of a successful treatment of hepatitis C virus on glyco-metabolic control in diabetic patients: a systematic review and meta-analysis. Acta Diabetologica 2019; 56(3) doi: 10.1007/s00592-018-1257-1
|
| 15 |
José Manuel Villalva-Pérez, Marco Antonio Ramírez-Vargas, Jesús Isimar Serafín-Fabían, Mónica Ramírez, Ma. Elena Moreno-Godínez, Mónica Espinoza-Rojo, Eugenia Flores-Alfaro. Characterization of Huh7 cells after the induction of insulin resistance and post-treatment with metformin. Cytotechnology 2020; 72(4) doi: 10.1007/s10616-020-00398-4
|
| 16 |
Justine Hum, Janice H. Jou, Pamela K. Green, Kristin Berry, James Lundblad, Barbara D. Hettinger, Michael Chang, George N. Ioannou. Improvement in Glycemic Control of Type 2 Diabetes After Successful Treatment of Hepatitis C Virus. Diabetes Care 2017; 40(9) doi: 10.2337/dc17-0485
|
| 17 |
Azizul Haque, Anudeep B. Pant. Viral Infections in Type 2 Diabetes: A Dangerous Liaison. Viruses 2025; 17(9) doi: 10.3390/v17091150
|
| 18 |
Yujin Ding, Guangdi Li, Zhiguang Zhou, Tuo Deng. Molecular mechanisms underlying hepatitis C virus infection-related diabetes. Metabolism 2021; 121 doi: 10.1016/j.metabol.2021.154802
|
| 19 |
Shen‐Shong Chang, Ching‐Hsuan Liu, Shu‐Yen Chan, Liang‐Tzung Lin. Hepatitis C Virus and Type 2 Diabetes: Mechanisms, Clinical Impact, and Post‐DAA Management. Journal of Medical Virology 2026; 98(5) doi: 10.1002/jmv.70952
|
| 20 |
Faiza Shams, Shazia Rafique, Sadia Zahid, Mobeen Munir, Muhammad Idrees, Muhammad Ilyas, Tayyab Husnain. Advances in the role of HCV nonstructural protein 5a (NS5A) of 3a genotype in inducing insulin resistance by possible phosphorylation of AKT/PKB. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-42602-2
|
| 21 |
Fumiaki Konishi, Teruki Miyake, Takao Watanabe, Yoshio Tokumoto, Shinya Furukawa, Bunzo Matsuura, Osamu Yoshida, Masumi Miyazaki, Akihito Shiomi, Sayaka Kanzaki, Hironobu Nakaguchi, Yoshiko Nakamura, Yusuke Imai, Mitsuhito Koizumi, Yasunori Yamamoto, Yohei Koizumi, Masashi Hirooka, Eiji Takeshita, Teru Kumagi, Yoshio Ikeda, Masanori Abe, Yoichi Hiasa. Association of abnormal glucose tolerance with liver‐related disease and cardiovascular diseases in patients with chronic hepatitis C. Hepatology Research 2023; 53(9) doi: 10.1111/hepr.13925
|
| 22 |
Chien-Hsieh Chiang, Chia-Sheng Kuo, Wan-Wan Lin, Jun-Han Su, Jin-De Chen, Kuo-Chin Huang. Chronic Viral Hepatitis Signifies the Association of Premixed Insulin Analogues with Liver Cancer Risks: A Nationwide Population-Based Study. International Journal of Environmental Research and Public Health 2019; 16(12) doi: 10.3390/ijerph16122097
|
| 23 |
Marco Infante, Nathalia Padilla, SriGita Madiraju, Ana Alvarez, David Baidal, Camillo Ricordi, Rodolfo Alejandro. Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas. 2020; doi: 10.1016/B978-0-12-814833-4.00037-X
|
| 24 |
Tatsuo Kanda, Taichiro Goto, Yosuke Hirotsu, Mitsuhiko Moriyama, Masao Omata. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review. International Journal of Molecular Sciences 2019; 20(6) doi: 10.3390/ijms20061358
|
| 25 |
Hang Xu, Xiaopeng Li, Hannah Adams, Karen Kubena, Shaodong Guo. Etiology of Metabolic Syndrome and Dietary Intervention. International Journal of Molecular Sciences 2018; 20(1) doi: 10.3390/ijms20010128
|
| 26 |
Ama Gassama-Diagne, Aline Awad. PI3K/SHIP2/PTEN pathway in cell polarity and hepatitis C virus pathogenesis. World Journal of Hepatology 2017; 9(1): 18-29 doi: 10.4254/wjh.v9.i1.18
|
| 27 |
Basant Mahmoud, Adel Abdel Moneim, Doaa Mabrouk. The impact of HCV eradication on hyperglycemia, insulin resistance, cytokine production, and insulin receptor substrate-1 and 2 expression in patients with HCV infection. Clinical and Experimental Medicine 2021; 22(4) doi: 10.1007/s10238-021-00773-1
|
| 28 |
Maria R. Emma, Giuseppa Augello, Antonella Cusimano, Antonina Azzolina, Giuseppe Montalto, James A. McCubrey, Melchiorre Cervello. GSK-3 in liver diseases: Friend or foe?. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2020; 1867(9) doi: 10.1016/j.bbamcr.2020.118743
|
| 29 |
Zakaria Boulahtouf, Alessia Virzì, Thomas F. Baumert, Eloi R. Verrier, Joachim Lupberger. Signaling Induced by Chronic Viral Hepatitis: Dependence and Consequences. International Journal of Molecular Sciences 2022; 23(5) doi: 10.3390/ijms23052787
|